Symtuza Tablet, Film Coated
Product Images NDC 59676-800

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Symtuza (NDC 59676-800). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Janssen Products Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Symtuza 01)

FDA Label Image

Chemical Structure (Symtuza 02)

FDA Label Image

Chemical Structure (Symtuza 03)

FDA Label Image

Chemical Structure (Symtuza 04)

FDA Label Image

Figure 1 (Symtuza 05)

Figure 1 (Symtuza 05)
This text seems to be a medical prescription or a report about medication during pregnancy. It is mentioning different drugs such as DARUNAVIR/cobicistat to be taken once daily during the second trimester and third trimester of pregnancy. It also appears to provide some data related to its concentration and level in the blood, but the text seems incomplete and difficult to understand.*
FDA Label Image

Principal Display Panel (30 Tablet Bottle Label)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.